IMMUNOGENE ZUSAMMENSETZUNG

Patent europeic · EP3513806 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3513806
Numer da la dumonda
EP19159001
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
03-12-2013
Publitgà
24-07-2019
Concedì
25-01-2023
La protecziun finescha il pli tard
02-12-2033
Proxima taxa annuala scadenta
31-12-2026
Classas IPC
A61K 39/08 (2006.01)
C07K 14/33 (2006.01)
Prioritad
GB 201221875 05.12.2012
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-01-2026

    Midada

    Published in Swissreg on 01.01.2026

  2. 01-01-2025

    Midada

    Published in Swissreg on 01.01.2025

  3. 01-01-2024

    Midada

    Published in Swissreg on 01.01.2024

  4. 06-12-2023

    Midada

    Published in Swissreg on 06.12.2023

  5. 24-02-2023

    Represchentant inscrit

    Representative
    AWA Switzerland Ltd., Case Postale 2243, 2800 Delémont 2

    Published in Swissreg on 24.02.2023

  6. 25-01-2023

    Concedì

    Published in Swissreg on 25.01.2023

Partidas

Possessur

GlaxoSmithKline Biologicals SA

Rue de l'Institut, 89, 1330 Rixensart, BE

Represchentant

AWA Switzerland SA

AWA Switzerland Ltd.

Case Postale 2243, 2800 Delémont 2

Inventur

BOUTRIAU, Dominique

1330 Rixensart, BE

WALLEMACQ, Hugues

1330 Rixensart, BE

GERMAIN, Sophie Marie Jeanne Valentine

1330 Rixensart, BE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.